A two day symposium to honor the work and legacy of Institute Professor Daniel I.C. Wang
November 4-5, 2021
MIT Media Lab
[Watch Event Videos]
Schedule
(All Times are US Eastern daylight Time)
Thursday, November 4, 2021
2pm – 5pm: Memories of Danny from alumni and colleagues
Reflections that established an enduring legacy – Danny Wang as a scholar, mentor, and friend.
Speakers
- Intro (Paula Hammond)
- Arthur E. Humphrey; Dean Emeritus of Engineering & Applied Sciences, University of Pennsylvania
- Jonathan Goldstein ’84, SM ’86; Senior Advisor, TA Associates
- Art Goldstein; Chairman & CEO Emeritus, Ionics, Incorporated
- Matt Croughan, PhD ’88; Industry consultant and CEO, Claymore Bio LLC
- Wei-Shou Hu, PhD ’84; Professor of Chemical Engineering & Materials Science, University of Minnesota
- Mike Thien, ScD ’88; Vice President, Merck
- Beth Junker, PhD ’89; Principal Consultant, BioProcess Advantage
- John Aunins, PhD ’89; Senior Advisor, Seres Therapeutics
15 minute Break
- Brian Kelley, PhD ’92; Senior Vice President, Vir Biotechnology
- Rahul Singhvi, ScD ’94; Co-founder & CEO, National Resilience, Inc.
- Sherry Gu, PhD ’97; Senior Vice President, WuXi Biologics
- Liangzhi Xie, ScD ’97; Chairman & CEO, Sinocelltech Group; Chairman, Sino Biological Inc.
- Araba Lamousé-Smith, PhD ’00: VP, Supply Chain & CMC Management, MacroGenics, Inc.
- Brian Baynes, PhD ’05; CEO, Verdox, Inc.
Friday, November 5, 2021
8:30am – 12pm: Reflections from the Frontlines of the Field
On Friday morning, we will discuss the impact of Danny’s groundbreaking work through conversations with leaders in the field.
8:30 – Intro (Paula Hammond)
8:40 – Phillip Sharp; Institute Professor of Biology, Koch Institute for Integrative Cancer Research
9:25 – Charles Cooney PhD ’70; Professor Emeritus, Chemical Engineering
10:10 – 15 Minute Break
10:25 – Kristala Prather ’94; Arthur D. Little Professor and Executive Officer, Chemical Engineering
11:10 – Noubar Afeyan PhD ’87; Founder and President, Flagship Pioneering
12 – 1pm: Lunch
1pm – 2pm: 2021 DIC Wang Lecture on the Frontiers of Biotechnology,
mRNA as Medicine, Melissa J. Moore PhD ‘89; Chief Scientific Officer, Platform Research, Moderna Therapeutics
2:30 – 5:30pm: Futures and Frontiers
A focus on the future of the biochemical engineering, biotechnology and its impact on society, inviting us to consider what Danny would be most excited about on the horizon.
2:35 – Reshma Shetty, PhD ’08; President, COO, & Co-Founder, Ginkgo Bioworks, Inc.
3:00 – Bernat Olle SM ’05, MBA ’07, PhD ’07; CEO and Co-Founder, Vedanta Biosciences
3:25 – Pearl Huang ’80, PhD; President & CEO, Cygnal Therapeutics
3:50 – 15 Minute Break
4:05 – Tassos Gianakakos ’94; CEO, MyoKardia
4:30 – Luis Alvarez SM ’99, PhD ’09; Founder, Theradaptive
4:55 – Konstantin Konstantinov, PhD; CTO, Codiak BioSciences
5:20pm: Reception